Index -
P/E 16.22
EPS (ttm) 21.77
Insider Own 1.75%
Shs Outstand 47.04M
Perf Week 4.09%
Market Cap 15.70B
Forward P/E 12.52
EPS next Y 28.19
Insider Trans -48.32%
Shs Float 43.71M
Perf Month 0.40%
Income 1.07B
PEG 0.92
EPS next Q 6.52
Inst Own 104.99%
Short Float 9.35%
Perf Quarter 11.69%
Sales 2.62B
P/S 6.00
EPS this Y 24.05%
Inst Trans 1.02%
Short Ratio 8.18
Perf Half Y 48.99%
Book/sh 128.25
P/B 2.75
EPS next Y 14.72%
ROA 15.96%
Short Interest 4.09M
Perf Year 57.64%
Cash/sh 66.79
P/C 5.29
EPS next 5Y 17.60%
ROE 19.25%
52W Range 208.62 - 366.08
Perf YTD 60.53%
Dividend Est. -
P/FCF 17.83
EPS past 5Y 8.15%
ROI 18.45%
52W High -3.57%
Beta 0.57
Dividend TTM -
Quick Ratio 4.18
Sales past 5Y 8.02%
Gross Margin 88.85%
52W Low 69.20%
ATR (14) 8.39
Dividend Ex-Date -
Current Ratio 4.35
EPS Y/Y TTM 22.46%
Oper. Margin 48.28%
RSI (14) 58.10
Volatility 2.24% 2.19%
Employees 1168
Debt/Eq 0.09
Sales Y/Y TTM 23.96%
Profit Margin 40.87%
Recom 2.12
Target Price 362.18
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q 11.81%
Payout 0.00%
Rel Volume 1.76
Prev Close 351.33
Sales Surprise 3.33%
EPS Surprise -9.79%
Sales Q/Q 19.85%
Earnings Jul 31 BMO
Avg Volume 499.39K
Price 353.00
SMA20 1.18%
SMA50 4.51%
SMA200 30.66%
Trades
Volume 878,358
Change 0.48%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-11-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$310 → $321
Feb-12-24 Upgrade
Goldman
Sell → Neutral
$213 → $215
Feb-05-24 Initiated
Leerink Partners
Outperform
$330
Dec-08-23 Initiated
Wells Fargo
Overweight
$309
Dec-06-22 Initiated
UBS
Buy
$320
Dec-05-22 Initiated
Goldman
Sell
$230
Oct-11-22 Initiated
Morgan Stanley
Overweight
$288
Sep-20-22 Reiterated
BofA Securities
Underperform
Sep-19-22 Resumed
Wedbush
Outperform
$263
Feb-11-22 Initiated
BTIG Research
Neutral
Jul-14-21 Upgrade
Argus
Hold → Buy
$205
Apr-26-21 Resumed
Credit Suisse
Outperform
$196
Feb-01-21 Upgrade
H.C. Wainwright
Neutral → Buy
$125 → $195
Sep-14-20 Resumed
JP Morgan
Overweight
$142
Jun-25-20 Reiterated
H.C. Wainwright
Neutral
$85 → $125
Mar-10-20 Upgrade
Jefferies
Hold → Buy
$123
Feb-27-20 Upgrade
Cowen
Market Perform → Outperform
$119 → $145
Jan-31-20 Upgrade
JP Morgan
Neutral → Overweight
$120
Dec-03-19 Initiated
BofA/Merrill
Underperform
Aug-01-19 Upgrade
Ladenburg Thalmann
Neutral → Buy
$103 → $106
Show Previous Ratings
Sep-10-24 07:00AM
Aug-30-24 12:02PM
11:31AM
Aug-28-24 07:00AM
Aug-22-24 07:01PM
07:08PM
Loading…
Aug-21-24 07:08PM
Aug-20-24 06:33AM
(Pharmaceutical Technology)
Aug-19-24 04:01PM
(Investor's Business Daily) +8.60%
Aug-05-24 07:01PM
Aug-04-24 01:33PM
Aug-02-24 12:00PM
09:45AM
Aug-01-24 10:41AM
(Investor's Business Daily)
01:06AM
Jul-31-24 11:39PM
(Morningstar Research) -7.18%
04:14PM
Loading…
04:14PM
(Investor's Business Daily)
12:45PM
09:51AM
09:50AM
09:30AM
09:17AM
(Investor's Business Daily)
07:40AM
06:47AM
(Associated Press Finance)
06:30AM
Jul-30-24 09:40AM
Jul-26-24 09:49AM
Jul-24-24 07:00AM
Jul-20-24 11:42AM
(Associated Press Finance)
Jul-17-24 09:45AM
Jul-15-24 09:04PM
12:45PM
Loading…
12:45PM
12:00PM
09:15AM
Jul-12-24 09:40AM
Jul-11-24 09:50AM
09:02AM
04:52AM
Jul-10-24 07:00AM
Jul-09-24 12:10PM
Jul-08-24 11:23AM
Jul-01-24 02:18PM
Jun-28-24 10:36AM
Jun-27-24 07:00AM
Jun-26-24 03:02PM
(Investor's Business Daily)
09:40AM
Jun-21-24 03:10AM
Jun-20-24 03:58PM
Jun-18-24 07:00PM
Jun-14-24 07:00PM
Jun-07-24 09:40AM
Jun-05-24 07:00AM
Jun-04-24 02:18PM
Jun-03-24 04:33PM
(Investor's Business Daily)
May-31-24 11:31AM
May-30-24 09:50AM
May-27-24 10:11AM
May-23-24 09:45AM
May-22-24 09:40AM
04:56AM
May-20-24 01:34PM
May-16-24 07:01PM
07:01PM
May-15-24 02:05AM
(Thomson Reuters StreetEvents)
May-14-24 04:39PM
May-10-24 04:41PM
May-09-24 11:47AM
May-08-24 05:15PM
09:50AM
May-07-24 05:00PM
02:23AM
02:23AM
May-06-24 04:43PM
02:30PM
12:45PM
09:45AM
09:15AM
May-05-24 08:19AM
May-03-24 07:50PM
04:39PM
02:41PM
May-02-24 11:59AM
11:43AM
11:35AM
09:54AM
03:12AM
01:06AM
12:07AM
(Thomson Reuters StreetEvents)
May-01-24 04:35PM
09:30AM
08:46AM
07:51AM
06:35AM
(Associated Press Finance)
06:30AM
Apr-29-24 12:00PM
Apr-26-24 02:02PM
Apr-24-24 12:10PM
10:01AM
09:00AM
07:00AM
Apr-23-24 04:39PM
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Olian Judy D. Director Sep 17 '24 Option Exercise 112.14 2,300 257,922 9,705 Sep 17 04:30 PM EDGEMOND JAMES CFO AND TREASURER Sep 16 '24 Option Exercise 118.99 8,334 991,622 7,140 Sep 17 04:30 PM EDGEMOND JAMES CFO AND TREASURER Sep 16 '24 Sale 339.12 7,810 2,648,527 3,740 Sep 17 04:30 PM JUDY OLIAN Director Sep 17 '24 Proposed Sale 353.22 2,300 812,406 Sep 17 04:04 PM JAMES EDGEMOND Officer Sep 16 '24 Proposed Sale 339.12 7,810 2,648,527 Sep 16 04:20 PM EDGEMOND JAMES CFO AND TREASURER Sep 09 '24 Option Exercise 118.98 8,332 991,381 6,610 Sep 10 04:30 PM EDGEMOND JAMES CFO AND TREASURER Sep 09 '24 Sale 345.41 7,802 2,694,889 3,210 Sep 10 04:30 PM JAMES EDGEMOND Officer Sep 09 '24 Proposed Sale 345.41 7,802 2,694,889 Sep 09 04:14 PM PATUSKY CHRISTOPHER Director Sep 04 '24 Option Exercise 175.43 4,300 754,349 5,200 Sep 05 04:30 PM PATUSKY CHRISTOPHER Director Sep 03 '24 Option Exercise 175.43 700 122,801 1,600 Sep 05 04:30 PM PATUSKY CHRISTOPHER Director Sep 04 '24 Sale 353.36 4,300 1,519,434 900 Sep 05 04:30 PM PATUSKY CHRISTOPHER Director Sep 03 '24 Sale 360.31 700 252,214 900 Sep 05 04:30 PM EDGEMOND JAMES CFO AND TREASURER Sep 03 '24 Option Exercise 118.98 8,332 991,381 6,015 Sep 04 04:34 PM EDGEMOND JAMES CFO AND TREASURER Sep 03 '24 Sale 362.37 7,785 2,821,050 2,615 Sep 04 04:34 PM CHRISTOPHER PATUSKY Director Sep 04 '24 Proposed Sale 353.36 4,300 1,519,434 Sep 04 04:14 PM CHRISTOPHER PATUSKY Director Sep 03 '24 Proposed Sale 360.31 700 252,214 Sep 03 04:35 PM JAMES EDGEMOND Officer Sep 03 '24 Proposed Sale 362.37 7,785 2,821,050 Sep 03 04:18 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 26 '24 Option Exercise 129.49 269 34,833 399 Aug 28 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 26 '24 Sale 348.41 269 93,723 130 Aug 28 04:30 PM EDGEMOND JAMES CFO AND TREASURER Aug 26 '24 Option Exercise 118.98 8,332 991,381 5,482 Aug 26 04:30 PM EDGEMOND JAMES CFO AND TREASURER Aug 26 '24 Sale 347.60 7,799 2,710,932 2,082 Aug 26 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 22 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 26 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 23 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 26 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 23 '24 Sale 348.11 3,600 1,253,198 130 Aug 26 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 22 '24 Sale 346.82 3,600 1,248,567 130 Aug 26 04:30 PM JAMES EDGEMOND Officer Aug 26 '24 Proposed Sale 347.60 7,799 2,710,932 Aug 26 04:24 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 20 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 22 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 21 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 22 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 21 '24 Sale 350.14 3,600 1,260,496 130 Aug 22 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 20 '24 Sale 346.03 3,600 1,245,698 130 Aug 22 04:30 PM CAUSEY CHRISTOPHER Director Aug 21 '24 Option Exercise 132.30 1,210 160,083 5,395 Aug 22 04:30 PM CAUSEY CHRISTOPHER Director Aug 21 '24 Sale 349.00 1,210 422,290 4,185 Aug 22 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 19 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 21 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 19 '24 Sale 344.18 3,600 1,239,047 130 Aug 21 04:30 PM CHRISTOPHER CAUSEY Director Aug 21 '24 Proposed Sale 349.00 1,210 422,290 Aug 21 04:05 PM EDGEMOND JAMES CFO AND TREASURER Aug 19 '24 Option Exercise 118.98 8,332 991,381 4,978 Aug 20 04:30 PM EDGEMOND JAMES CFO AND TREASURER Aug 19 '24 Sale 329.02 7,828 2,575,569 1,578 Aug 20 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 15 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 19 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 16 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 19 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 15 '24 Sale 323.32 3,600 1,163,965 130 Aug 19 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 16 '24 Sale 320.68 3,600 1,154,432 130 Aug 19 04:30 PM JAMES EDGEMOND Officer Aug 19 '24 Proposed Sale 329.02 7,828 2,575,569 Aug 19 04:25 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 13 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 15 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 14 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 15 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 13 '24 Sale 327.84 3,600 1,180,221 130 Aug 15 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 14 '24 Sale 324.50 3,600 1,168,205 130 Aug 15 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 09 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 13 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 12 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 13 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 12 '24 Sale 334.14 3,600 1,202,909 130 Aug 13 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 09 '24 Sale 330.48 3,600 1,189,712 130 Aug 13 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 07 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 09 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 08 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 09 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 08 '24 Sale 328.39 3,600 1,182,205 130 Aug 09 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 07 '24 Sale 324.01 3,600 1,166,437 130 Aug 09 04:30 PM BENKOWITZ MICHAEL PRESIDENT AND COO Aug 07 '24 Option Exercise 118.41 25,000 2,960,200 20,000 Aug 08 04:30 PM BENKOWITZ MICHAEL PRESIDENT AND COO Aug 07 '24 Sale 323.38 25,000 8,084,473 0 Aug 08 04:30 PM M BENKOWITZ & M R BENKOWITZ CO Officer Aug 07 '24 Proposed Sale 323.37 20,000 6,467,448 Aug 07 05:17 PM DANIEL CARLSON TTEE BENKOWITZ Officer Aug 07 '24 Proposed Sale 323.40 5,000 1,617,024 Aug 07 05:16 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 05 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 07 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 06 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 07 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 06 '24 Sale 325.45 3,600 1,171,625 130 Aug 07 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 05 '24 Sale 321.64 3,600 1,157,916 130 Aug 07 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 01 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 05 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 02 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 05 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 02 '24 Sale 324.73 3,600 1,169,043 130 Aug 05 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Aug 01 '24 Sale 323.91 3,600 1,166,066 130 Aug 05 04:30 PM DWEK RAYMOND Director Aug 02 '24 Option Exercise 175.43 5,000 877,150 6,750 Aug 05 04:30 PM DWEK RAYMOND Director Aug 02 '24 Sale 325.35 5,000 1,626,735 1,750 Aug 05 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 31 '24 Option Exercise 129.49 3,600 466,164 3,730 Aug 02 05:13 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 31 '24 Sale 318.39 3,600 1,146,210 130 Aug 02 05:13 PM RAYMOND DWEK Director Aug 02 '24 Proposed Sale 325.35 5,000 1,626,734 Aug 02 04:08 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 29 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 31 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 30 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 31 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 30 '24 Sale 337.40 3,600 1,214,630 130 Jul 31 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 29 '24 Sale 335.72 3,600 1,208,605 130 Jul 31 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 25 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 29 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 26 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 29 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 25 '24 Sale 338.89 3,600 1,219,999 130 Jul 29 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 26 '24 Sale 338.61 3,600 1,219,011 130 Jul 29 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 23 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 25 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 24 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 25 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 23 '24 Sale 335.38 3,600 1,207,368 130 Jul 25 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 24 '24 Sale 334.00 3,600 1,202,414 130 Jul 25 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 19 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 23 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 22 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 23 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 22 '24 Sale 331.32 3,600 1,192,738 130 Jul 23 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 19 '24 Sale 329.59 3,600 1,186,506 130 Jul 23 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 17 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 19 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 18 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 19 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 17 '24 Sale 333.69 3,600 1,201,298 130 Jul 19 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 18 '24 Sale 331.79 3,600 1,194,438 130 Jul 19 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 15 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 17 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 16 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 17 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 16 '24 Sale 328.03 3,600 1,180,909 130 Jul 17 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 15 '24 Sale 326.29 3,600 1,174,636 130 Jul 17 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 11 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 15 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 12 '24 Option Exercise 129.49 3,600 466,164 3,730 Jul 15 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 11 '24 Sale 325.96 3,600 1,173,470 130 Jul 15 04:30 PM ROTHBLATT MARTINE A Chairperson & CEO Jul 12 '24 Sale 324.97 3,600 1,169,875 130 Jul 15 04:30 PM PATUSKY CHRISTOPHER Director Jul 13 '24 Option Exercise 0.00 900 0 900 Jul 15 04:30 PM
Index S&P 500
P/E 47.37
EPS (ttm) 0.46
Insider Own 0.35%
Shs Outstand 699.29M
Perf Week -2.52%
Market Cap 15.39B
Forward P/E 94.81
EPS next Y 0.23
Insider Trans 0.00%
Shs Float 696.82M
Perf Month 0.55%
Income 287.14M
PEG -
EPS next Q 0.06
Inst Own 93.18%
Short Float 1.48%
Perf Quarter 14.40%
Sales 2.41B
P/S 6.38
EPS this Y -39.50%
Inst Trans -1.78%
Short Ratio 2.14
Perf Half Y 23.51%
Book/sh 12.51
P/B 1.76
EPS next Y -31.49%
ROA 1.60%
Short Interest 10.33M
Perf Year 10.60%
Cash/sh 0.23
P/C 96.62
EPS next 5Y -12.59%
ROE 3.76%
52W Range 15.24 - 22.79
Perf YTD 11.16%
Dividend Est. 1.20 (5.45% )
P/FCF 17.93
EPS past 5Y -24.23%
ROI 1.61%
52W High -3.42%
Beta 1.12
Dividend TTM 1.20 (5.45% )
Quick Ratio -
Sales past 5Y 5.92%
Gross Margin 23.28%
52W Low 44.42%
ATR (14) 0.40
Dividend Ex-Date Aug 05, 2024
Current Ratio -
EPS Y/Y TTM -52.12%
Oper. Margin 18.92%
RSI (14) 50.49
Volatility 2.18% 1.72%
Employees 193
Debt/Eq 1.04
Sales Y/Y TTM 13.99%
Profit Margin 11.91%
Recom 1.63
Target Price 24.07
Option/Short Yes / Yes
LT Debt/Eq 1.04
EPS Q/Q 119.34%
Payout 215.83%
Rel Volume 2.30
Prev Close 21.90
Sales Surprise 4.57%
EPS Surprise 109.79%
Sales Q/Q 27.51%
Earnings Jul 25 AMC
Avg Volume 4.84M
Price 22.01
SMA20 -0.88%
SMA50 1.52%
SMA200 12.89%
Trades
Volume 11,123,509
Change 0.50%
Date
Action
Analyst
Rating Change
Price Target Change
May-03-24 Upgrade
Wedbush
Neutral → Outperform
Apr-26-24 Upgrade
Exane BNP Paribas
Neutral → Outperform
$19 → $21
Apr-22-24 Resumed
Mizuho
Buy
$22
Apr-01-24 Upgrade
BofA Securities
Underperform → Buy
$18 → $25
Mar-25-24 Resumed
Wells Fargo
Equal Weight
$19
Mar-08-24 Resumed
RBC Capital Mkts
Outperform
$21
Jan-05-24 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
May-26-23 Initiated
JMP Securities
Mkt Outperform
$15.50
Apr-20-23 Initiated
Wells Fargo
Underweight
$14
Dec-14-22 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$17
Oct-28-22 Initiated
JP Morgan
Neutral
$17
Aug-05-22 Downgrade
Colliers Securities
Buy → Neutral
$19
Jun-03-22 Initiated
CapitalOne
Equal Weight
$20
May-19-22 Downgrade
BofA Securities
Neutral → Underperform
$18
Apr-26-22 Initiated
Barclays
Overweight
$20
Feb-01-22 Initiated
Credit Suisse
Neutral
$19
Jan-07-22 Downgrade
BMO Capital Markets
Outperform → Market Perform
$20
Sep-13-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$20
Aug-20-21 Downgrade
Raymond James
Outperform → Mkt Perform
Jun-14-21 Downgrade
Robert W. Baird
Outperform → Neutral
$19 → $20
Show Previous Ratings
Sep-13-24 12:15PM
Sep-11-24 12:10PM
Aug-23-24 07:14PM
Aug-19-24 12:00PM
Jul-26-24 11:04AM
(Morningstar Research) +5.49%
04:15PM
Loading…
Jul-25-24 04:15PM
Jul-22-24 02:00PM
Jul-12-24 09:22AM
Jun-27-24 03:52PM
Jun-24-24 05:43PM
Jun-20-24 04:15PM
Jun-19-24 06:45AM
Jun-13-24 04:15PM
May-30-24 04:15PM
May-07-24 04:15PM
03:07AM
Loading…
Apr-27-24 03:07AM
01:05AM
Apr-26-24 04:07PM
Apr-25-24 04:15PM
Apr-04-24 04:15PM
Mar-04-24 02:06PM
Feb-26-24 06:04PM
04:15PM
Feb-21-24 08:00PM
07:10PM
06:18PM
(Associated Press Finance)
05:33PM
05:00PM
05:00PM
Feb-12-24 08:28AM
08:32AM
Loading…
Feb-10-24 08:32AM
Jan-27-24 12:07PM
Jan-26-24 12:12PM
Jan-09-24 04:02PM
Jan-01-24 11:03AM
Dec-21-23 07:00AM
Nov-09-23 09:44AM
06:14AM
Nov-07-23 01:52PM
Nov-02-23 06:23AM
05:35AM
Nov-01-23 11:46AM
10:12AM
Oct-31-23 09:13PM
07:40AM
Oct-30-23 12:17PM
11:31AM
(The Wall Street Journal)
09:30AM
08:15AM
07:30AM
(The Wall Street Journal)
07:17AM
07:09AM
(Associated Press Finance)
07:05AM
06:59AM
06:59AM
Oct-02-23 07:02AM
Sep-21-23 06:00AM
Sep-15-23 01:05AM
Sep-13-23 09:08PM
Aug-26-23 07:47AM
Aug-03-23 10:00AM
09:05AM
07:59AM
(Associated Press Finance)
07:52AM
Jul-24-23 05:45PM
08:41AM
Jul-19-23 06:00AM
Jul-11-23 10:00AM
Jul-05-23 05:13AM
Jul-03-23 09:37PM
Jun-21-23 08:00PM
Jun-16-23 07:45AM
Jun-05-23 07:15AM
May-24-23 05:45PM
May-16-23 05:13AM
May-05-23 01:42AM
(Thomson Reuters StreetEvents)
May-04-23 09:30AM
09:05AM
08:02AM
07:51AM
May-02-23 05:45PM
Apr-26-23 08:00PM
Apr-24-23 05:13AM
Mar-28-23 10:05AM
Mar-27-23 08:07AM
Mar-21-23 10:21AM
Mar-17-23 07:00AM
Mar-15-23 07:03AM
Mar-08-23 08:06AM
Mar-01-23 04:01AM
Feb-23-23 04:32PM
Feb-22-23 09:05AM
07:51AM
Feb-16-23 09:10AM
Jan-27-23 08:30AM
Jan-21-23 09:15AM
Jan-13-23 03:57PM
Jan-02-23 07:24AM
Dec-22-22 05:00AM
Dec-04-22 08:39PM
Healthpeak Properties, Inc. is a Standard & Poor's 500 company, which engages in acquiring, developing, owning, leasing, and managing healthcare real estate across the United States. It operates through the following segments: Lab, Outpatient Medical, Continuing Care Retirement Community (CCRC), and Other Non-Reportable. The Lab segment refers to lab properties, which contain laboratory and office space. The Outpatient Medical segment includes outpatient medical buildings and hospitals. The CCRC segment deals with retirement communities that include independent living, assisted living, memory care, and skilled nursing units. The Other Non-Reportable segment consists of an unconsolidated joint venture with a sovereign wealth fund that owns 19 senior housing assets and loans receivable. The company was founded in 1985 and is headquartered in Denver, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hall Amy M SVP-Leasing&Physician Strategy Dec 08 '23 Sale 12.58 4,001 50,333 35,824 Dec 12 04:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite